C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/47 (2006.01)
Patent
CA 2390778
The application discloses markers associated with organ transplant rejection and associated conditions, and in particular provides materials and methods for the diagnosis, prognosis or treatment of chronic rejection of transplanted organ such as heart and kidney. Examples of the markers include ribosomal protein L7, .beta.-transducin, 1-TRAF (also known as TANK) or lysyl-tRNA synthetase, or antibodies against these antigens.
La présente invention concerne des marqueurs associés au rejet d'un organe transplanté et les états pathologiques associés, et concerne en particulier des matériaux et des procédés permettant de diagnostiquer, de prévoir ou de traiter le rejet chronique d'un organe transplanté tel qu'un coeur ou un rein. Les marqueurs comprennent par exemple la protéine ribosomale L7, la .beta.-transducine, la 1-TRAF (appelée également TANK) ou lysyl-ARNt synthase, ou des anticorps contre ces antigènes.
Dunn Michael John
Linke Adam
Rose Marlene Lydia
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Dunn Michael John
Imperial Innovations Ltd
Linke Adam
Rose Marlene Lydia
LandOfFree
Organ transplant rejection and associated conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organ transplant rejection and associated conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organ transplant rejection and associated conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398565